| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Lipid Research, Vol 21, 53-64, Copyright © 1980 by Lipid Research, Inc.
ARTICLES |
L Svennerholm, MT Vanier and JE Mansson
The primary genetic defect underlying Krabbe disease or globoid cell leukodystrophy is considered to be a deficiency of galactosylceramide- beta-galactosidase. In the present study of the brains from 18 patients who had died from Krabbe disease at 7-37 months of age, the concentration of galactosylceramide of cerebral and cerebellar white matter was severely reduced to 10-20% of that in age-matched controls. The lowest values were found in the most long-standing cases. Lactosylceramide was reduced to about 50% of normal, while globotriaosylceramide, blobotetraosylceramide and III3-alpha- fucosylneolactotetraosylceramide were increased 10 to 100-fold. Two glycosphingolipids, which have never before been isolated from normal human brains were now isolated and characterized: galactosylsphingosine (psychosine) and galactosyl beta 1 leads to 4 galactosylceramide. We were unable to identify galactosylsphingosine in normal human brains with certainty. We estimate its concentration in the cerebral white matter in Krabbe disease to be increased at least 100-fold (higher than normal). Psychosine was isolated also from the cerebral cortex in Psychosine was isolated also from the cerebral cortex in Krabbe disease after derivatization to the N-acetyl form. Its concentration there was 1 nmol/g tissue compared with 6-10 nmol/g in the white matter. All the neutral glycosphingolipids were isolated and their structure proved by the quantitative determination of their components, degradation by acid and specific glycohydrolases and permethylation and gas-liquid chromatographic-mass spectrometric assay of the methylated sugars. The paradoxical findings of a severely reduced concentration of galactosylceramide and a primary deficiency of cerebroside-beta- galactosidase can be explained by the present finding of the accumulation of galactosylsphingosine in the brains from patients who had died from Krabbe disease. The enzyme has a broad specificity and it normally also degrades galactosylsphingosine. Because of competitive inhibition by the accumulated galactosylceramide its lysosomal hydrolysis will be blocked. The concentration of psychosine will steadily increase and reach toxic levels and kill the oligodendroglial cells. This results in an arrest of the galactosylceramide biosynthesis. Therefore, we feel that galactosylsphingosine and not galactosylceramide is the primary storage substance in the brain in Krabbe disease that the disease is a psychosine lipidosis.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J. M. Aerts, J. E. Groener, S. Kuiper, W. E. Donker-Koopman, A. Strijland, R. Ottenhoff, C. van Roomen, M. Mirzaian, F. A. Wijburg, G. E. Linthorst, et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease PNAS, February 26, 2008; 105(8): 2812 - 2817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nakagawa, A. Morotomi, M. Tani, N. Sueyoshi, H. Komori, and M. Ito C18:3-GM1a induces apoptosis in Neuro2a cells: enzymatic remodeling of fatty acyl chains of glycosphingolipids J. Lipid Res., June 1, 2005; 46(6): 1103 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ishii, Y. Kihara, and T. Shimizu Identification of T Cell Death-associated Gene 8 (TDAG8) as a Novel Acid Sensing G-protein-coupled Receptor J. Biol. Chem., March 11, 2005; 280(10): 9083 - 9087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Suzuki Globoid Cell Leukodystrophy (Krabbe's Disease): Update J Child Neurol, September 1, 2003; 18(9): 595 - 603. [Abstract] [PDF]
|
|
|
|
|
|
J. Bodennec, S. Trajkovic-Bodennec, and A. H. Futerman Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride J. Lipid Res., July 1, 2003; 44(7): 1413 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lloyd-Evans, D. Pelled, C. Riebeling, J. Bodennec, A. de-Morgan, H. Waller, R. Schiffmann, and A. H. Futerman Glucosylceramide and Glucosylsphingosine Modulate Calcium Mobilization from Brain Microsomes via Different Mechanisms J. Biol. Chem., June 20, 2003; 278(26): 23594 - 23599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bodennec, D. Pelled, and A. H. Futerman Aminopropyl solid phase extraction and 2 D TLC of neutral glycosphingolipids and neutral lysoglycosphingolipids J. Lipid Res., January 1, 2003; 44(1): 218 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dasgupta, S. B. Levery, and E. L. Hogan 3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide J. Lipid Res., May 1, 2002; 43(5): 751 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. GIRI, M. JATANA, R. RATTAN, J.-S. WON, I. SINGH, and A. K. SINGH Galactosylsphingosine (psychosine) -induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease FASEB J, May 1, 2002; 16(7): 661 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Whitfield, P. C. Sharp, R. Taylor, and P. Meikle Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry J. Lipid Res., December 1, 2001; 42(12): 2092 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Matsuda, M. T. Vanier, Y. Saito, K. Suzuki, and K. Suzuki Dramatic phenotypic improvement during pregnancy in a genetic leukodystrophy: estrogen appears to be a critical factor Hum. Mol. Genet., November 1, 2001; 10(23): 2709 - 2715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sueyoshi, T. Maehara, and M. Ito Apoptosis of Neuro2a cells induced by lysosphingolipids with naturally occurring stereochemical configurations J. Lipid Res., August 1, 2001; 42(8): 1197 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.J. Mitchison Psychosine, Cytokinesis, and Orphan Receptors: Unexpected Connections J. Cell Biol., April 16, 2001; 153(2): F1 - F4. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tohyama, M. T. Vanier, K. Suzuki, T. Ezoe, J. Matsuda, and K. Suzuki Paradoxical influence of acid {beta}-galactosidase gene dosage on phenotype of the twitcher mouse (genetic galactosylceramidase deficiency) Hum. Mol. Genet., July 1, 2000; 9(11): 1699 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kanazawa, S. Nakamura, M. Momoi, T. Yamaji, H. Takematsu, H. Yano, H. Sabe, A. Yamamoto, T. Kawasaki, and Y. Kozutsumi Inhibition of Cytokinesis by a Lipid Metabolite, Psychosine J. Cell Biol., May 15, 2000; 149(4): 943 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kurita, H. Izu, M. Sano, M. Ito, and I. Kato Enhancement of hydrolytic activity of sphingolipid ceramide N-deacylase in the aqueous-organic biphasic system J. Lipid Res., May 1, 2000; 41(5): 846 - 851. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-M. ZAHM, C. GALABERT, A. CHAFFIN, J.-P. CHAZALETTE, C. GROSSKOPF, and E. PUCHELLE Improvement of Cystic Fibrosis Airway Mucus Transportability by Recombinant Human DNase Is Related to Changes in Phospholipid Profile Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1779 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Percy Review Article: The Inherited Neurodegenerative Disorders of Childhood: Clinical Assessment J Child Neurol, April 1, 1987; 2(2): 82 - 97. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Hannun and R. Bell Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses Science, February 6, 1987; 235(4789): 670 - 674. [Abstract] [PDF]
|
|
|
|
|
|
H Igisu and K Suzuki Progressive accumulation of toxic metabolite in a genetic leukodystrophy Science, May 18, 1984; 224(4650): 753 - 755. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
